	First-line envafolimab plus recombinant human-endostatin inÂ advanced non-small cell lung cancer with PD-L1 tumor proportion score â‰¥1% (Endouble): A multicenter, prospective, single-arm, phase 2 trial. Cancer Dong C, Liu L, Qiao Y, Wang M, Song D, Zhou L, Ji Y, Li Y, Ding F, Wang H, Zhuang M, Wang L, Liu Z, Fei H, Guo X, Bian B, Yuan C, Xu G, Fang L, Li Y, Song Z, Hui K, Jiang X. PMID: 42216493 [PubMed - indexed for MEDLINE]
	Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry. Cancer Passiglia F, Passaro A, Gariazzo E, Montrone M, Pasello G, Tiseo M, Russano M, Citarella F, Muscarella LA, Pozzessere D, Bria E, Roca E, Cerea G, Russo A, Grisanti S, Bulotta A, Veccia A, Biello F, Lo Russo G, Pilotto S, Genova C, Cortinovis D, Minuti G, Meoni G, Gori S, Reale ML, Pavan A, Ramundo M, Grossi F, Parra HS, Scotti V, Vavalà T, Sini C, Sergi C, Pelizzari G, Chiari R, Stanzione B, Favaretto A, Leone F, Bettini AC, Pagano M, Tondulli L, Toschi L, Lacidogna G, Bennati C, Catanese S, Malapelle U, Giannarelli D, Novello S. PMID: 42216441 [PubMed - indexed for MEDLINE]
	Predictive value of the prothrombin time-to-albumin ratio for 28- and 90-day mortality in lung cancer patients admitted to the intensive care unit: A retrospective cohort study. Medicine (Baltimore) Jia F, Xia G, Xu T, Hu L, Wu S, Liu L, Lei X. PMID: 42216324 [PubMed - indexed for MEDLINE]
	Safety, pharmacokinetics, pharmacodynamics and antitumor activity of legubicin in patients with advanced solid tumors, including lung cancer: a phase 1 dose-escalation and expansion trial. BMC Cancer Lin F, Xue J, Li Q, Tang W, Zhao W, Xue L, Zhou J, Liu Y, Jin W, Sun H, Liu C, Guo Y, Li J. PMID: 42215940 [PubMed - as supplied by publisher]
	Effects of different telehabilitation methods on postoperative pulmonary rehabilitation of patients with lung cancer: a systematic review and network meta-analysis of randomised controlled trials protocol. BMJ Open Liu J, Niu H, Li J, Chen Q, Bi H. PMID: 42215264 [PubMed - indexed for MEDLINE]
	Integration of habitat radiomics and 2.5D deep features from (18)F-FDG PET/CT for noninvasive prediction of PD-L1 TPSÂ â‰¥Â 50% in non-small cell lung cancer. Eur J Radiol Yang F, Wang D, Wang D, Wang H, Li X, Zhao Y, Shi L, Cai Y, Ke S, Li P. PMID: 42214904 [PubMed - as supplied by publisher]
	Metabolic-epigenetic crosstalk in lung cancer: Glycolytic reprogramming and lactylation-driven macrophage polarization. Pathol Res Pract Wang C, Liu S, Fan J, Liu L, Sun Y. PMID: 42214873 [PubMed - as supplied by publisher]
	Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial. Lancet Xiong A, Yao W, Zheng W, Yu Y, Chen P, Zhong H, Ge J, Wang H, Chen B, Wang H, Fan Y, Yang Y, Pu X, Song X, Wang Q, Du X, Huang Z, Li X, Luo H, Yao Y, Yu Q, Su C, He L, Jiang G, Cui J, Liu C, Yi T, Che G, Liu Z, Zhang L, Zhou M, Fang Y, Wei Y, Qing Y, Jin X, Zhou C. PMID: 42214392 [PubMed - as supplied by publisher]
	Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases. Clin Lung Cancer Aliouat A, Chareire A, Bodergat T, Moncharmont C, Pierre C, Geier M, Lasvergnas J, Zysman M, Pinsolle J, Guibert C, Perrot E, Tekhneriadov A, Pons-Tostivint E, Toffart AC. PMID: 42214267 [PubMed - as supplied by publisher]
	Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies. Lung Cancer Burotto M, Zvirbule Z, Alvarez R, Chewaskulyong B, Felip E, Majem M, Korbenfeld E, Kolb-Sielecki J, Isla D, Barata T, Bustillos A, Herraez-Baranda LA, Tosti N, Young F, Zanghi J, Cappuzzo F. PMID: 42214243 [PubMed - as supplied by publisher]
	Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan. JCO Glob Oncol El Khatib O, Obeidat N, Yaseen A, Khader R, Al-Yagoub M, Haroon N, Zayed A, Ghlailat M, Hamadneh Y, Al-Showbaki L, Haddad H, Yaser S, Mahmoud N, Abdel Jalil R, Al-Batsh T, Abdel Rahman Z, Shahin O, Ma'koseh M, Halahleh K, Al-Ibraheem A, Al-Jaghbeer MJ, Aljadayeh MH, Al Maani J, Tamimi F, Al-Rabi K. PMID: 42214046 [PubMed - indexed for MEDLINE]
	The association and risk prediction of the ubiquitination pathway genetic variants and lung cancer incidence: A nested case-control study. Cancer Epidemiol Biomarkers Prev Mao J, Leng L, Zhu T, Wang J, Zhao G, Liu X, Liu H, Wu Y, Cheng L, Zhang R. PMID: 42213488 [PubMed - as supplied by publisher]
	Tumor budding in non-small cell lung cancer: a new prognostic frontier? Updates Surg Çakmak H, Çiflik KB, Aktürk S, , Özdemir Çiflik B, Beyo. PMID: 42213351 [PubMed - as supplied by publisher]
	Practices in reporting incidental findings in lung cancer screening by low-dose CT: a European Survey of Radiologists by SOLACE. Insights Imaging Ledda RE, Nischwitz E, Kauczor HU, Revel MP, Ko, Vogel-Clausen J, Blum TG, Chorostowska-Wynimko J, Prosch H, Kerpel-Fronius A, SOLACE Collaborative Authors. PMID: 42213298 [PubMed]
	Pre-weekend effect in pulmonary resection for non-small cell lung cancer: a multicenter retrospective cohort study. Surg Today Hamaji M, Miyamoto S, Sozu T, Ohsumi A, Kobayashi M, Nakagawa T, Sonobe M, Aoyama A, Ishikawa M, Sakai H, Miyahara R, Menju T, Date H, Chen-Yoshikawa TF. PMID: 42213118 [PubMed - as supplied by publisher]
	Interventions for smoking cessation in people undergoing lung cancer screening. Cochrane Database Syst Rev Marshall HM, Bendotti H, Morphett K, Harrison NJ, Waldmann JY, Chan G, Fidler A, Allerton S, Runge C, Brooke M, Lawler S, Gartner CE, Yang IA, Fong K. PMID: 42212788 [PubMed - indexed for MEDLINE]
	Diagnostic Value of Coagulation-Fibrinolysis Biomarkers for Metastasis in Lung, Ovarian, Breast, and Colorectal Cancers. Clin Appl Thromb Hemost Zhao Y, Sun X, Lin B, Xu S, Gao H. PMID: 42212702 [PubMed - indexed for MEDLINE]
	Immune network remodeling driven by ferroptosis: Bidirectional interaction mechanisms among multiple immune cells in the lung cancer immune microenvironment (Review). Oncol Rep Qu F, Tong J, Qian W, He Q. PMID: 42212386 [PubMed - indexed for MEDLINE]
	Targeting lung cancer with tanshinones: Current mechanistic evidence and emerging opportunities (Review). Oncol Rep Guo Z, Li X, Suo P, Lin Z, Liu R, Chi C. PMID: 42212375 [PubMed - indexed for MEDLINE]
	Development and validation of the Pulmonary Nodule Malignant Transformation Fear Scale (PN-MTFS) to identify patients at high risk of cancer-related fear: a multicenter study. Front Psychol Wang X, Zhou G, Song C, Zhang H, Tang X, Wang X, Yang N, Chen Q. PMID: 42212040 [PubMed]

Articles 1 - 20 / 159123

Page 1 of 7957



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy